BioCentury
ARTICLE | Company News

Azee Inc., Oscient deal

July 11, 2005 7:00 AM UTC

Azee received a license from OSCI to an undisclosed IP that relates to Azee's small molecule anti-genomic therapeutics (SMATs), which bind DNA. OSCI received an equity stake in Azee and is eligible fo...